FIELD: medicine; pharmacology.
SUBSTANCE: this invention concerns medical products, specifically application of oxcarbasepine which has particles of average size 2 to 12 mcm and maximal sieving remains through sieve aperture size 40 mcm not exceeding 5% for medical product applied for management, preventions or treatments of attacks for requiring patient. Besides, present invention concerns oral dosed form including oxcarbasepine with characteristics specified above, packed together with written instructions.
EFFECT: provided oxcarbasepine action regardless of meals.
10 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DELAYED-RELEASE ORAL DOSAGE FORM OF GABAPENTIN | 2005 |
|
RU2440112C2 |
| CEFUROXIMAXETIL-CONTAINING COMBINATIONS | 1999 |
|
RU2248794C2 |
| FLUVASTATIN CONTAINING PHARMACEUTICAL COMPOSITIONS | 2001 |
|
RU2297223C2 |
| TERBINAFINE SOLID MEDICINAL FORMULATION FOR ORAL ADMINISTRATION | 2002 |
|
RU2298402C2 |
| TABLET WITH FILM COATING CONTAINING OXACARBAZEPINE | 1998 |
|
RU2201218C2 |
| OXCARBAZEPINE-CONTAINING SUSPENSION | 2000 |
|
RU2277912C2 |
| METHOD FOR TREATING METABOLISM DISORDERS MAINLY DIABETES CASES AND DISEASES OR STATES RELATED TO DIABETES | 2000 |
|
RU2280447C2 |
| SLOW-RELEASE TABLET WITH SPECIFIED CORE GEOMETRY | 2004 |
|
RU2391093C2 |
| PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2316324C2 |
| TABLETS OF TAMSULOSIN WITH MODIFIED RELEASE | 2002 |
|
RU2335280C2 |
